Search research articles
Contact Us
Filters
Showing results (21-30 of 37) with videos related to
Page
of 4
Sort By:
Seminars in Oncology
|
January 10, 2006
Morbidity and mortality are not increased after induction chemoradiotherapy followed by esophagectomy in patients with esophageal cancer
Adam C Berger, Walter J Scott, Gary Freedman, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
March 23, 2005
Complete response to neoadjuvant chemoradiotherapy in esophageal carcinoma is associated with significantly improved survival
Adam C Berger, Jeffrey Farma, Walter J Scott, et al.
Journal of Laparoendoscopic & Advanced Surgical Techniques. Part A
|
August 5, 2017
Benefits of Supplemental Jejunostomy Tube Feeding During Neoadjuvant Therapy in Patients with Locally Advanced, Potentially Resectable Esophageal Cancer
Brian G A Dalton, Adam J Friedant, Stacey Su, et al.
The Annals of Thoracic Surgery
|
March 31, 2005
The surgical management of superior sulcus tumors: a retrospective review with long-term follow-up
Melvyn Goldberg, Dipin Gupta, Aaron R Sasson, et al.
The Journal of Thoracic and Cardiovascular Surgery
|
December 3, 2013
Patterns of survival and recurrence after surgical treatment of early stage non-small cell lung carcinoma in the ACOSOG Z0030 (ALLIANCE) trial
Stacey Su, Walter J Scott, Mark S Allen, et al.
The Annals of Thoracic Surgery
|
December 3, 2014
Increased time from neoadjuvant chemoradiation to surgery is associated with higher pathologic complete response rates in esophageal cancer
Talha Shaikh, Karen Ruth, Walter J Scott, et al.
The Application of Clinical Genetics
|
March 4, 2015
Bilateral granulosa cell tumors: a novel malignant manifestation of multiple endocrine neoplasia 1 syndrome found in a patient with a rare menin in-frame deletion
Michael J Hall, Julie Innocent, Christina Rybak, et al.
The Journal of Thoracic and Cardiovascular Surgery
|
February 23, 2010
Video-assisted thoracic surgery versus open lobectomy for lung cancer: a secondary analysis of data from the American College of Surgeons Oncology Group Z0030 randomized clinical trial
Walter J Scott, Mark S Allen, Gail Darling, et al.
American Journal of Clinical Oncology
|
March 18, 2016
Induction Therapy for Locally Advanced, Resectable Esophagogastric Cancer: A Phase I Trial of Vandetanib (ZD6474), Paclitaxel, Carboplatin, 5-Fluorouracil, and Radiotherapy Followed by Resection
Patrick M Boland, Joshua E Meyer, Adam C Berger, et al.
Annals of Surgery
|
December 25, 2009
Optimum lymphadenectomy for esophageal cancer
Nabil P Rizk, Hemant Ishwaran, Thomas W Rice, et al.
Page
of 4
Search research articles
Search
Showing results (21-30 of 37) with videos related to
Sort By:
Page
of 4
Seminars in Oncology
|
January 10, 2006
Morbidity and mortality are not increased after induction chemoradiotherapy followed by esophagectomy in patients with esophageal cancer
Adam C Berger, Walter J Scott, Gary Freedman, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
March 23, 2005
Complete response to neoadjuvant chemoradiotherapy in esophageal carcinoma is associated with significantly improved survival
Adam C Berger, Jeffrey Farma, Walter J Scott, et al.
Journal of Laparoendoscopic & Advanced Surgical Techniques. Part A
|
August 5, 2017
Benefits of Supplemental Jejunostomy Tube Feeding During Neoadjuvant Therapy in Patients with Locally Advanced, Potentially Resectable Esophageal Cancer
Brian G A Dalton, Adam J Friedant, Stacey Su, et al.
The Annals of Thoracic Surgery
|
March 31, 2005
The surgical management of superior sulcus tumors: a retrospective review with long-term follow-up
Melvyn Goldberg, Dipin Gupta, Aaron R Sasson, et al.
The Journal of Thoracic and Cardiovascular Surgery
|
December 3, 2013
Patterns of survival and recurrence after surgical treatment of early stage non-small cell lung carcinoma in the ACOSOG Z0030 (ALLIANCE) trial
Stacey Su, Walter J Scott, Mark S Allen, et al.
The Annals of Thoracic Surgery
|
December 3, 2014
Increased time from neoadjuvant chemoradiation to surgery is associated with higher pathologic complete response rates in esophageal cancer
Talha Shaikh, Karen Ruth, Walter J Scott, et al.
The Application of Clinical Genetics
|
March 4, 2015
Bilateral granulosa cell tumors: a novel malignant manifestation of multiple endocrine neoplasia 1 syndrome found in a patient with a rare menin in-frame deletion
Michael J Hall, Julie Innocent, Christina Rybak, et al.
The Journal of Thoracic and Cardiovascular Surgery
|
February 23, 2010
Video-assisted thoracic surgery versus open lobectomy for lung cancer: a secondary analysis of data from the American College of Surgeons Oncology Group Z0030 randomized clinical trial
Walter J Scott, Mark S Allen, Gail Darling, et al.
American Journal of Clinical Oncology
|
March 18, 2016
Induction Therapy for Locally Advanced, Resectable Esophagogastric Cancer: A Phase I Trial of Vandetanib (ZD6474), Paclitaxel, Carboplatin, 5-Fluorouracil, and Radiotherapy Followed by Resection
Patrick M Boland, Joshua E Meyer, Adam C Berger, et al.
Annals of Surgery
|
December 25, 2009
Optimum lymphadenectomy for esophageal cancer
Nabil P Rizk, Hemant Ishwaran, Thomas W Rice, et al.
Page
of 4